UPL Ltd. announces an acquisition

Under UPL Limited's proposed group reorganization announced on February 20, 2026, the share entitlement ratio for the demerger of the India crop protection business into the new entity (UPL Global) is 1 equity share of UPL Global (INR 2 face value) for every 1 equity share held in UPL Limited (INR 2 face value) ^[1].

Valuation Reports and Alignment

• Valuation Basis: The share entitlement and exchange ratios were determined based on a joint valuation report dated February 20, 2026, prepared by registered independent valuers PwC Business Consulting Services LLP and Ernst & Young Merchant Banking Services LLP ^[1].
• Fairness Opinion: J.P. Morgan India Private Limited issued a fairness opinion on February 20, 2026, confirming that the proposed share entitlement and exchange ratios are fair from a financial point of view ^[1].
• Methodology Alignment: The valuation utilized relative valuation methodologies across the multi-step scheme (which also includes the merger of UPL SAS into UPL Ltd and UPL Corp into UPL Global) to ensure transparency, objectivity, and arm's-length alignment with corporate governance standards ^[2].

Implications

• Proportionate Value Translation: The 1:1 entitlement ratio for the vertical demerger establishes a mirror-holding structure, ensuring that existing public and promoter shareholders of UPL Limited receive an equivalent direct stake in UPL Global alongside their continued holding in UPL Limited ^[2].
• Value Discovery: By discharging consideration entirely through shares rather than cash, the structure avoids debt-funded cash outflows while unlocking value by separating the pure-play global crop protection platform from the diversified specialty chemicals and agricultural platform ^[1].

The provided Scheme of Arrangement documents and associated rating rationales do not explicitly disclose an absolute rupee-denominated or percentage allocation of UPL’s consolidated net debt between the retained entity (UPL Ltd.) and the demerged entity (UPL Global) ^[3]. However, rating agency disclosures provide the specific pro-forma leverage expectations (Net Debt/EBITDA) for both entities post-restructuring ^[3].

Pro-Forma Leverage Ratios Post-Restructuring

• UPL Global (Demerged / Resulting Entity): Projected to operate at a pro-forma Net Debt/EBITDA ratio of 2.00x to 2.30x during its listing year ^[3]. This is based on estimated TTM 2025 revenues of approximately Rs 40,000 Crore and an operating profitability (EBITDA margin) of 15.5% ^[3].
• Retained Entity (UPL Ltd. Post-Demerger): Projected to achieve a consolidated Net Debt/EBITDA ratio of ~1.80x in FY26, improving from 1.94x in FY25 and 5.30x in FY24 ^[3]. For context, UPL's total consolidated net debt stood at Rs 23,317 Crore as of December 31, 2025 (up from Rs 15,172 Crore as of March 31, 2025, due to seasonal working capital requirements) ^[3].

Analytical Implications

• Structural Ring-Fencing: The demerger aims to establish UPL Global as a standalone global crop protection pure-play with clear leverage visibility (~2.0x–2.3x Net Debt/EBITDA), enabling investors to benchmark it directly against international peers rather than pricing in a conglomerate discount [news_index_1, _index_5].
• Retained Entity Deleveraging Drivers: The retained UPL entity—housing the Advanta seeds platform, specialty chemicals, and incubation businesses—relies on operational cash flow generation, working capital normalization, non-recourse receivables securitization, and potential stake monetizations (such as Advanta) to support its targeted leverage reduction ^[4].

Limits and Disclosure Gaps

The exact debt-transfer schedules, debt-split formulas, or definitive inter-company liability allocations contained within the final NCLT Scheme of Arrangement filings are not explicitly detailed in the retrieved source documents.

Following the receipt of the No-Objection letters from BSE and NSE on July 29, 2026 ^[5], the remaining conditions precedent for UPL’s Composite Scheme of Arrangement involve formal NCLT filing and review timelines, convening requisite shareholder and creditor meetings, and fulfilling statutory listing and regulatory conditions.

NCLT Approval Timeline and Process

• NCLT Filing Window: The observation letters mandate that the Scheme must be submitted to the National Company Law Tribunal (NCLT) within six months from the date of issuance, setting a deadline of January 29, 2027 ^[6].
• Overall Transaction Timeline: The broader execution roadmap targets completion of the entire reorganization within 12 to 15 months from the initial board approval in February 2026 ^[7].
• Post-Filing Milestones: Following the NCLT filing, the process requires NCLT review and convening of meetings, receipt of the final NCLT order, filing of the NCLT order with the Registrar of Companies (ROC), and the issuance and listing of shares of UPL Global within 60 days of receiving the NCLT order ^[2].

Shareholder and Creditor Voting Thresholds

• Shareholder Approvals: The Scheme requires approval from the shareholders of the respective companies involved ^[8]. Specifically, the reorganization is required to be approved by a majority of UPL's minority shareholders to safeguard their interests ^[2].
• Creditor Consents: The company is required to obtain necessary consents from creditors for the proposed scheme in accordance with the provisions of the Companies Act, 2013 ^[9].
• Disclosure Note: While specific statutory voting majorities (such as the standard three-fourths [75%] in value under Sections 230–232 of the Companies Act, 2013) govern NCLT scheme approvals, the exact numerical thresholds beyond the majority of minority shareholders and general creditor consent are governed by the statutory framework rather than explicitly detailed numeric cutoffs in the exchange correspondence.